Practical Implementation of ADA/EASD Consensus Algorithm in Patients With Type 2 Diabetes: Timely Insulin Initiation and Titration.
Latest Information Update: 08 Nov 2021
Price :
$35 *
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms AFICIONADO; LANTUS
- Sponsors Sanofi
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jul 2012 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 08 Dec 2011 Planned End Date changed from 1 Nov 2011 to 1 Sep 2012 as reported by ClinicalTrials.gov.